ACRUX LTD.
Research ACRUX LTD. (FJY) on Bullrun: market cap EUR 1.18M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFJY
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 1.18M
- Financial periodFY2025
- RevenueAUD 1.19M
- Revenue growth-76.6%
- Net income-AUD 5.95M
- Free cash flow-AUD 5.48M
- Gross margin100.0%
Valuation Snapshot
latest market cap is EUR 1.18M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 1.19M | -AUD 5.95M | -AUD 5.48M | 100.0% | -0.02 | AUD 863.00K | AUD 3.64M | AUD 1.02M |
| FY2024 | AUD 5.09M | -AUD 5.80M | -AUD 4.58M | 22.3% | -0.02 | AUD 2.95M | AUD 3.70M | AUD 3.28M |
| FY2023 | AUD 8.43M | -AUD 764.00K | AUD 584.00K | 93.4% | 0 | AUD 6.23M | AUD 2.35M | AUD 8.70M |
| FY2022 | AUD 1.72M | -AUD 9.83M | -AUD 9.28M | 100.0% | -0.03 | AUD 5.83M | AUD 2.08M | AUD 9.09M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | EUR 1.18M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About ACRUX LTD.
Acrux Limited, together with its subsidiaries, develops and commercializes topically applied pharmaceutical products in Australia, the United States, Europe, and internationally. The company offers Dapsone 7.5% and 5% gels for the treatment of acne vulgaris; Nitroglycerine 0.4% ointments for the treatment of moderate to severe pain associated with chronic anal fissure; Lidocaine and Prilocaine creams USP 2.5% for local analgesia and pre-treatment for infiltration anesthesia;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ACRUX LTD.'s market cap?
ACRUX LTD.'s market capitalization is EUR 1.18M.
What does ACRUX LTD. do?
Acrux Limited, together with its subsidiaries, develops and commercializes topically applied pharmaceutical products in Australia, the United States, Europe, and internationally.